This is to inform that, pursuant to the SEBI (PIT) Reg, 2015, read with the relevant circulars issued by BSE Limited and Company''s Code of Conduct for prevention of Insider trading of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed the stock exchanges that its trading window will be closed from 1st January 2026 until 48 hours after the announcement of its quarterly financial results for the period ending 31st December 2025 (Q3 FY26). During this window, all designated persons and their immediate relatives are prohibited from trading in the company's shares. This is a routine compliance filing under SEBI's Insider Trading Regulations. The exact date of the board meeting to approve the Q3 results has not yet been disclosed and will be communicated later.
This is a standard regulatory disclosure with no material impact on shareholders or the stock price. It signals that the company's Q3 FY26 earnings announcement is approaching, which investors should watch for.